Anti-epileptic Agent [EPC]

Anti-epileptic Agent [EPC] was reported 221159 times

Drugs of the Anti-epileptic Agent [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 INFANTILE SPASMS 381 0.5270
1 SUDDEN UNEXPLAINED DEATH IN EPILEPSY 273 0.5103
2 FOCAL DYSCOGNITIVE SEIZURES 526 0.4618
3 ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC 297 0.4569
4 PARTIAL SEIZURES WITH SECONDARY GENERALISATION 198 0.4231
5 SIMPLE PARTIAL SEIZURES 332 0.4114
6 DRUG WITHDRAWAL CONVULSIONS 720 0.4045
7 MULTIPLE-DRUG RESISTANCE 1254 0.4040
8 ANTICONVULSANT DRUG LEVEL INCREASED 610 0.3775
9 ANTICONVULSANT DRUG LEVEL DECREASED 496 0.3510
10 SEIZURE CLUSTER 278 0.3353
11 HYPERAMMONAEMIC ENCEPHALOPATHY 570 0.3276
12 LIP EROSION 239 0.3274
13 MAGNETIC RESONANCE IMAGING HEAD ABNORMAL 205 0.3159
14 CHANGE IN SEIZURE PRESENTATION 203 0.3138
15 ATONIC SEIZURES 266 0.3097
16 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 225 0.2988
17 FOETAL ANTICONVULSANT SYNDROME 344 0.2901
18 MYOCLONIC EPILEPSY 429 0.2826
19 CEREBELLAR ATROPHY 241 0.2736
20 COMPLEX PARTIAL SEIZURES 301 0.2707
21 PETIT MAL EPILEPSY 1312 0.2567
22 FACET JOINT SYNDROME 805 0.2470
23 STATUS EPILEPTICUS 2552 0.2257
24 PARTIAL SEIZURES 1182 0.2255
25 AURA 413 0.2212
26 ORAL MUCOSA EROSION 257 0.2089
27 OVERLAP SYNDROME 146 0.2086
28 TONIC CONVULSION 289 0.2038
29 PSYCHOGENIC SEIZURE 186 0.1989
30 DYSMORPHISM 444 0.1883
31 NYSTAGMUS 983 0.1850
32 EPILEPSY 5540 0.1811
33 HYPERAMMONAEMIA 906 0.1810
34 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 562 0.1730
35 ELECTROENCEPHALOGRAM ABNORMAL 542 0.1715
36 STEVENS-JOHNSON SYNDROME 3780 0.1699
37 BLEPHAROSPASM 1054 0.1672
38 SELECTIVE EATING DISORDER 152 0.1670
39 PERIPHERAL VENOUS DISEASE 681 0.1666
40 GENERALISED TONIC-CLONIC SEIZURE 2738 0.1653
41 ONYCHOMADESIS 685 0.1631
42 ATAXIA 1818 0.1530
43 SCHIZOAFFECTIVE DISORDER 267 0.1496
44 INTELLECTUAL DISABILITY 221 0.1455
45 HYPOSPADIAS 297 0.1427
46 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 3571 0.1386
47 GRAND MAL CONVULSION 1274 0.1378
48 BREAST CANCER STAGE III 874 0.1348
49 SEIZURE 15433 0.1335
50 POLYDACTYLY 154 0.1328
51 CONVULSION 7392 0.1291
52 PSYCHOMOTOR RETARDATION 354 0.1258
53 TOXIC EPIDERMAL NECROLYSIS 1870 0.1230
54 RESPIRATORY DISORDER NEONATAL 199 0.1227
55 HYPOMANIA 444 0.1206
56 PSYCHOMOTOR SKILLS IMPAIRED 314 0.1198
57 SPINA BIFIDA 248 0.1189
58 RHEUMATIC FEVER 530 0.1188
59 BRAIN OPERATION 269 0.1177
60 DUODENAL ULCER PERFORATION 872 0.1171
61 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 836 0.1166
62 LIVE BIRTH 962 0.1149
63 ONYCHOMYCOSIS 494 0.1125
64 BIPOLAR I DISORDER 246 0.1120
65 CLEFT PALATE 210 0.1086
66 GAZE PALSY 184 0.1079
67 HYPOTONIA NEONATAL 166 0.1062
68 BIPOLAR DISORDER 1131 0.1039
69 BEHAVIOUR DISORDER 533 0.0984
70 STARING 238 0.0984
71 PSYCHIATRIC DECOMPENSATION 190 0.0971
72 NEUROLEPTIC MALIGNANT SYNDROME 1133 0.0954
73 MANIA 1567 0.0952
74 TALIPES 293 0.0942
75 DRUG LEVEL INCREASED 1537 0.0928
76 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 385 0.0926
77 DISLOCATION OF VERTEBRA 211 0.0924
78 OCULOGYRIC CRISIS 198 0.0922
79 SPEECH DISORDER DEVELOPMENTAL 262 0.0913
80 MUSCLE INJURY 752 0.0907
81 ANTIPSYCHOTIC DRUG LEVEL INCREASED 251 0.0891
82 CEREBELLAR SYNDROME 195 0.0889
83 RASH MORBILLIFORM 246 0.0886
84 DEPRESSIVE SYMPTOM 311 0.0881
85 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 449 0.0875
86 VENTRICULAR SEPTAL DEFECT 500 0.0872
87 HYPERREFLEXIA 303 0.0869
88 ATRIAL SEPTAL DEFECT 728 0.0868
89 FOLLICULITIS 909 0.0866
90 HELICOBACTER INFECTION 882 0.0857
91 NAIL DISORDER 748 0.0854
92 CLONUS 233 0.0851
93 SEDATION COMPLICATION 217 0.0850
94 INFUSION SITE REACTION 254 0.0849
95 SUSPECTED SUICIDE 393 0.0838
96 WRONG PATIENT RECEIVED PRODUCT 244 0.0833
97 LIP DRY 755 0.0830
98 AMMONIA INCREASED 418 0.0818
99 HYPERCHOLESTEROLAEMIA 788 0.0815
100 MYOCLONUS 968 0.0811
101 PERSECUTORY DELUSION 200 0.0801
102 CEREBRAL ATROPHY 319 0.0799
103 DRUG LEVEL DECREASED 808 0.0793
104 STUPOR 253 0.0787
105 CATATONIA 413 0.0786
106 BURSITIS 953 0.0785
107 PEMPHIGUS 976 0.0780
108 PATENT DUCTUS ARTERIOSUS 308 0.0775
109 STRABISMUS 225 0.0765
110 WOUND INFECTION 838 0.0764
111 PARADOXICAL DRUG REACTION 272 0.0739
112 CONJUNCTIVAL HYPERAEMIA 262 0.0734
113 FINGER DEFORMITY 353 0.0728
114 OBESITY 1158 0.0726
115 HAND DEFORMITY 934 0.0711
116 HYPERNATRAEMIA 349 0.0700
117 CONGENITAL ANOMALY 541 0.0698
118 MATERNAL DRUGS AFFECTING FOETUS 535 0.0697
119 CLUMSINESS 190 0.0696
120 LOGORRHOEA 245 0.0695
121 BACK INJURY 751 0.0690
122 C-REACTIVE PROTEIN ABNORMAL 437 0.0681
123 OBSESSIVE-COMPULSIVE DISORDER 544 0.0677
124 SEDATION 1748 0.0667
125 DIABETES INSIPIDUS 160 0.0664
126 DRUG INTERACTION 10510 0.0662
127 IMPULSIVE BEHAVIOUR 248 0.0660
128 COORDINATION ABNORMAL 920 0.0659
129 COMPLETED SUICIDE 5470 0.0656
130 GAMBLING DISORDER 177 0.0655
131 DRUG ERUPTION 1161 0.0654
132 PERSONALITY DISORDER 171 0.0652
133 PARKINSONISM 634 0.0650
134 PERICARDITIS 1088 0.0647
135 DRUG LEVEL BELOW THERAPEUTIC 353 0.0639
136 AGGRESSION 3177 0.0634
137 HYPOTONIA 633 0.0633
138 DRUG SCREEN FALSE POSITIVE 174 0.0628
139 GRIP STRENGTH DECREASED 550 0.0624
140 EYE MOVEMENT DISORDER 424 0.0619
141 DRUG EXPOSURE DURING PREGNANCY 2069 0.0608
142 NEONATAL RESPIRATORY DISTRESS SYNDROME 214 0.0604
143 TACHYPHRENIA 209 0.0603
144 JOINT RANGE OF MOTION DECREASED 809 0.0603
145 EXPOSURE VIA BREAST MILK 240 0.0602
146 RASH MACULO-PAPULAR 1306 0.0586
147 SEROTONIN SYNDROME 1122 0.0584
148 FOETAL EXPOSURE DURING PREGNANCY 4747 0.0583
149 DRUG TITRATION ERROR 149 0.0577
150 COMA SCALE ABNORMAL 167 0.0576
151 PSYCHOTIC DISORDER 1702 0.0576
152 ERYTHEMA MULTIFORME 535 0.0573
153 DROOLING 395 0.0571
154 ENURESIS 229 0.0566
155 PRODUCT LABEL CONFUSION 330 0.0566
156 HYPERTHERMIA 431 0.0564
157 HOSTILITY 143 0.0562
158 DIPLOPIA 1456 0.0560
159 INTENTIONAL SELF-INJURY 1132 0.0560
160 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 417 0.0555
161 AFFECTIVE DISORDER 436 0.0554
162 MATERNAL EXPOSURE DURING BREAST FEEDING 225 0.0554
163 DEPRESSION SUICIDAL 191 0.0551
164 SUICIDAL BEHAVIOUR 228 0.0548
165 HOMICIDAL IDEATION 219 0.0540
166 SALIVARY HYPERSECRETION 540 0.0539
167 TOXIC ENCEPHALOPATHY 272 0.0536
168 GENERALISED ERYTHEMA 300 0.0527
169 SYNOVITIS 945 0.0524
170 SUICIDE ATTEMPT 3175 0.0523
171 INTENTIONAL OVERDOSE 3341 0.0520
172 GLOSSODYNIA 1166 0.0520
173 HALLUCINATION, AUDITORY 821 0.0516
174 PSYCHOMOTOR HYPERACTIVITY 857 0.0516
175 AUTISM SPECTRUM DISORDER 284 0.0515
176 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 529 0.0515
177 MENINGITIS ASEPTIC 230 0.0512
178 HYPERTONIA 291 0.0508
179 TRIGEMINAL NEURALGIA 204 0.0507
180 RESPIRATORY ACIDOSIS 198 0.0503
181 DRUG TOXICITY 686 0.0503
182 SMALL FOR DATES BABY 249 0.0501
183 ENCEPHALOPATHY 1230 0.0500
184 BRUXISM 269 0.0498
185 AKATHISIA 679 0.0497
186 NORMAL NEWBORN 270 0.0496
187 POSTURE ABNORMAL 161 0.0494
188 ABNORMAL BEHAVIOUR 1958 0.0494
189 METABOLIC ENCEPHALOPATHY 148 0.0493
190 HYPOTHERMIA 494 0.0487
191 DEVELOPMENTAL DELAY 440 0.0487
192 TYPE 2 DIABETES MELLITUS 1642 0.0487
193 DEPRESSED LEVEL OF CONSCIOUSNESS 1925 0.0486
194 COMA 2313 0.0485
195 TOXICITY TO VARIOUS AGENTS 8171 0.0484
196 POISONING 606 0.0482
197 POISONING DELIBERATE 456 0.0481
198 MUSCLE RIGIDITY 575 0.0480
199 SWOLLEN JOINT COUNT INCREASED 153 0.0479
200 COGNITIVE DISORDER 2231 0.0477
201 DRUG LEVEL ABOVE THERAPEUTIC 218 0.0475
202 MAJOR DEPRESSION 346 0.0473
203 MULTIPLE DRUG OVERDOSE INTENTIONAL 152 0.0472
204 COELIAC DISEASE 461 0.0469
205 PARANOIA 808 0.0468
206 STILLBIRTH 226 0.0467
207 FIBROMYALGIA 1137 0.0467
208 IRRITABLE BOWEL SYNDROME 996 0.0464
209 PRE-EXISTING CONDITION IMPROVED 289 0.0462
210 DERMATITIS EXFOLIATIVE 229 0.0457
211 AGITATION 3358 0.0457
212 FEELING DRUNK 339 0.0456
213 TEARFULNESS 196 0.0455
214 TASTE DISORDER 923 0.0455
215 IRRITABILITY 2724 0.0453
216 ALTERED STATE OF CONSCIOUSNESS 981 0.0452
217 HALLUCINATIONS, MIXED 189 0.0449
218 TIC 244 0.0447
219 COMMUNICATION DISORDER 171 0.0447
220 MULTIPLE DRUG OVERDOSE 221 0.0445
221 HYPONATRAEMIA 2506 0.0444
222 DYSARTHRIA 1670 0.0443
223 RASH VESICULAR 213 0.0440
224 SCREAMING 280 0.0439
225 EXPOSURE DURING PREGNANCY 2731 0.0439
226 PRESCRIBED OVERDOSE 849 0.0438
227 HYPERACUSIS 163 0.0437
228 THERAPEUTIC AGENT TOXICITY 146 0.0437
229 SUICIDAL IDEATION 4004 0.0437
230 ANXIETY DISORDER 146 0.0437
231 DYSKINESIA 1773 0.0436
232 ABORTION INDUCED 408 0.0433
233 BLOOD PROLACTIN INCREASED 204 0.0432
234 DELUSION 672 0.0432
235 PRODUCT ADMINISTRATION INTERRUPTED 339 0.0431
236 LYMPHADENOPATHY 1520 0.0429
237 ANGER 1450 0.0428
238 PNEUMONIA ASPIRATION 1068 0.0427
239 LIVER INJURY 1048 0.0427
240 SOMNOLENCE 8483 0.0421
241 DRUG RESISTANCE 1068 0.0415
242 SELF-INJURIOUS IDEATION 174 0.0414
243 MATERNAL EXPOSURE DURING PREGNANCY 3645 0.0409
244 BRAIN OEDEMA 516 0.0408
245 C-REACTIVE PROTEIN INCREASED 1485 0.0408
246 DISSOCIATION 312 0.0407
247 PRODUCT SUBSTITUTION ISSUE 2343 0.0407
248 AFFECT LABILITY 390 0.0405
249 WOUND 1131 0.0404
250 MENTAL STATUS CHANGES 1119 0.0403
251 EOSINOPHILIA 703 0.0401
252 ELECTROCARDIOGRAM QT PROLONGED 1442 0.0400
253 TOXIC SKIN ERUPTION 396 0.0393
254 HYPOGAMMAGLOBULINAEMIA 258 0.0392
255 DYSPHEMIA 172 0.0392
256 VISUAL FIELD DEFECT 283 0.0391
257 PSYCHIATRIC SYMPTOM 289 0.0391
258 SOCIAL AVOIDANT BEHAVIOUR 226 0.0390
259 SNORING 146 0.0386
260 GRANULOCYTOPENIA 220 0.0386
261 RASH GENERALISED 990 0.0382
262 MUSCLE TWITCHING 879 0.0381
263 ABORTION SPONTANEOUS 1513 0.0377
264 DISTURBANCE IN ATTENTION 2033 0.0377
265 MYDRIASIS 483 0.0376
266 SOMNAMBULISM 247 0.0376
267 DISORIENTATION 1491 0.0376
268 APNOEA 292 0.0375
269 SCHIZOPHRENIA 454 0.0373
270 CHEILITIS 202 0.0373
271 APATHY 543 0.0372
272 CEREBRAL DISORDER 275 0.0371
273 HYPERPHAGIA 148 0.0371
274 GESTATIONAL DIABETES 176 0.0369
275 POLYDIPSIA 146 0.0369
276 MOTOR DYSFUNCTION 376 0.0369
277 DELIRIUM 1276 0.0367
278 INFARCTION 251 0.0366
279 ASPIRATION 398 0.0363
280 DRUG SCREEN POSITIVE 287 0.0363
281 BUNDLE BRANCH BLOCK RIGHT 166 0.0361
282 ATTENTION DEFICIT HYPERACTIVITY DISORDER 152 0.0361
283 DRUG-INDUCED LIVER INJURY 1132 0.0360
284 BRADYPHRENIA 235 0.0359
285 UNRESPONSIVE TO STIMULI 924 0.0358
286 THINKING ABNORMAL 667 0.0358
287 HALLUCINATION, VISUAL 753 0.0356
288 ADVERSE REACTION 472 0.0356
289 BALANCE DISORDER 3075 0.0355
290 CAESAREAN SECTION 414 0.0355
291 SYSTEMIC LUPUS ERYTHEMATOSUS 1259 0.0354
292 SOPOR 469 0.0354
293 DYSTONIA 685 0.0353
294 MENTAL IMPAIRMENT 856 0.0353
295 CONCUSSION 273 0.0352
296 BRADYKINESIA 208 0.0352
297 DRUG TOLERANCE 178 0.0352
298 MYOCARDITIS 403 0.0351
299 BLISTER 1974 0.0351
300 CRYING 1273 0.0350
301 HYPERSOMNIA 996 0.0347
302 APHASIA 1048 0.0347
303 DEPRESSION 7869 0.0346
304 RESPIRATORY DEPRESSION 422 0.0344
305 RESTLESSNESS 1246 0.0340
306 HAEMODYNAMIC INSTABILITY 259 0.0340
307 POST-TRAUMATIC STRESS DISORDER 227 0.0338
308 CARDIO-RESPIRATORY ARREST 1416 0.0338
309 ILEUS PARALYTIC 151 0.0338
310 BLOOD SODIUM DECREASED 635 0.0337
311 DIABETIC NEUROPATHY 166 0.0335
312 MOOD ALTERED 910 0.0333
313 SLEEP APNOEA SYNDROME 636 0.0333
314 VISUAL DISTURBANCE 191 0.0333
315 FEELING OF DESPAIR 155 0.0332
316 SINUS TACHYCARDIA 471 0.0331
317 MOOD SWINGS 1056 0.0331
318 TREMOR 5450 0.0328
319 INCOHERENT 211 0.0326
320 CONFUSIONAL STATE 5256 0.0325
321 LIVER FUNCTION TEST INCREASED 698 0.0325
322 FACE OEDEMA 545 0.0323
323 DYSPHORIA 163 0.0322
324 APLASTIC ANAEMIA 168 0.0321
325 TRISMUS 166 0.0321
326 RESPIRATORY ARREST 884 0.0320
327 SPEECH DISORDER 1680 0.0320
328 PRE-ECLAMPSIA 152 0.0320
329 BLOOD LACTIC ACID INCREASED 167 0.0317
330 LEUKOCYTOSIS 573 0.0316
331 DECREASED INTEREST 186 0.0315
332 GAMMA-GLUTAMYLTRANSFERASE INCREASED 699 0.0315
333 LETHARGY 1809 0.0314
334 PHARYNGOLARYNGEAL PAIN 165 0.0310
335 NIGHT SWEATS 997 0.0309
336 BLOOD CHOLESTEROL INCREASED 1437 0.0308
337 BLOOD CREATINE PHOSPHOKINASE INCREASED 886 0.0307
338 PREMATURE LABOUR 174 0.0307
339 PRODUCT SUPPLY ISSUE 219 0.0306
340 CONTRAINDICATED PRODUCT ADMINISTERED 927 0.0306
341 PREGNANCY 613 0.0306
342 MEMORY IMPAIRMENT 4202 0.0306
343 EUPHORIC MOOD 313 0.0305
344 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 270 0.0305
345 PERSONALITY CHANGE 282 0.0303
346 EXTRAPYRAMIDAL DISORDER 749 0.0301
347 HEPATITIS 769 0.0300
348 AMNESIA 1951 0.0300
349 ENCEPHALITIS 207 0.0299
350 ORAL DISORDER 218 0.0297
351 BRAIN INJURY 297 0.0296
352 ACUTE HEPATIC FAILURE 403 0.0295
353 SLEEP DISORDER 2078 0.0294
354 HYDROCEPHALUS 160 0.0293
355 LUPUS-LIKE SYNDROME 266 0.0293
356 EXOSTOSIS 267 0.0292
357 DYSGRAPHIA 192 0.0291
358 IMPAIRED HEALING 955 0.0291
359 MOUTH ULCERATION 608 0.0288
360 LOW BIRTH WEIGHT BABY 229 0.0288
361 METABOLIC DISORDER 167 0.0287
362 HEAD INJURY 899 0.0284
363 PAPULE 200 0.0284
364 METABOLIC ACIDOSIS 906 0.0283
365 MENTAL DISORDER 1230 0.0282
366 ACIDOSIS 216 0.0282
367 EOSINOPHIL COUNT INCREASED 235 0.0282
368 DERMATITIS BULLOUS 204 0.0282
369 GAIT INABILITY 936 0.0280
370 CONJUNCTIVITIS 517 0.0278
371 OSTEOARTHRITIS 1181 0.0278
372 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 216 0.0278
373 TARDIVE DYSKINESIA 784 0.0278
374 MIGRAINE 2625 0.0275
375 PHOTOPHOBIA 514 0.0273
376 ODYNOPHAGIA 163 0.0273
377 NEUROLOGICAL SYMPTOM 156 0.0273
378 HEPATIC ENZYME INCREASED 1860 0.0273
379 PURPURA 241 0.0272
380 HYPERVENTILATION 157 0.0271
381 TREATMENT NONCOMPLIANCE 1480 0.0270
382 MIOSIS 217 0.0270
383 URINARY INCONTINENCE 798 0.0269
384 SUDDEN DEATH 285 0.0269
385 RHABDOMYOLYSIS 1120 0.0268
386 TYPE 1 DIABETES MELLITUS 161 0.0267
387 PREMATURE BABY 804 0.0267
388 BRAIN NEOPLASM 245 0.0266
389 RESTLESS LEGS SYNDROME 476 0.0261
390 AGRANULOCYTOSIS 486 0.0261
391 PSORIATIC ARTHROPATHY 1056 0.0260
392 INTESTINAL ISCHAEMIA 143 0.0259
393 INCREASED APPETITE 495 0.0259
394 FOETAL GROWTH RESTRICTION 156 0.0256
395 PANIC ATTACK 929 0.0255
396 DEPRESSED MOOD 1337 0.0253
397 DISSEMINATED INTRAVASCULAR COAGULATION 355 0.0252
398 NEUTROPHIL COUNT INCREASED 258 0.0252
399 WITHDRAWAL SYNDROME 1058 0.0252
400 ENERGY INCREASED 148 0.0251
401 PRESCRIBED UNDERDOSE 500 0.0250
402 CARDIAC ARREST 2065 0.0250
403 INCONTINENCE 264 0.0250
404 RED BLOOD CELL SEDIMENTATION RATE INCREASED 276 0.0249
405 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1366 0.0249
406 RASH 10729 0.0246
407 VITAMIN D DEFICIENCY 240 0.0246
408 BLOOD CALCIUM DECREASED 276 0.0245
409 MOVEMENT DISORDER 788 0.0245
410 HYPERPROLACTINAEMIA 159 0.0245
411 THERAPEUTIC RESPONSE CHANGED 155 0.0244
412 IMPAIRED DRIVING ABILITY 277 0.0243
413 VENTRICULAR FIBRILLATION 270 0.0243
414 HALLUCINATION 1829 0.0242
415 INFLAMMATION 1244 0.0241
416 GASTROOESOPHAGEAL REFLUX DISEASE 1934 0.0240
417 RESPIRATORY DISTRESS 663 0.0240
418 VERTIGO 1461 0.0239
419 RECALLED PRODUCT ADMINISTERED 228 0.0239
420 HYPOKINESIA 345 0.0237
421 HEPATOMEGALY 232 0.0236
422 BLOOD ALBUMIN DECREASED 187 0.0235
423 MATERNAL EXPOSURE BEFORE PREGNANCY 161 0.0235
424 HEPATOCELLULAR INJURY 334 0.0235
425 LOSS OF CONSCIOUSNESS 3018 0.0235
426 STOMATITIS 1428 0.0235
427 TRANSAMINASES INCREASED 523 0.0235
428 TONGUE DISORDER 170 0.0235
429 INITIAL INSOMNIA 241 0.0235
430 TREATMENT FAILURE 1939 0.0234
431 EATING DISORDER 497 0.0233
432 PIGMENTATION DISORDER 144 0.0233
433 DRUG DISPENSING ERROR 356 0.0233
434 APPETITE DISORDER 154 0.0232
435 ELECTROCARDIOGRAM ABNORMAL 182 0.0232
436 ANXIETY 6507 0.0228
437 POOR QUALITY SLEEP 492 0.0228
438 CARDIAC MURMUR 197 0.0227
439 SINUS BRADYCARDIA 220 0.0227
440 COLITIS ISCHAEMIC 153 0.0227
441 REFUSAL OF TREATMENT BY PATIENT 148 0.0226
442 RASH PUSTULAR 165 0.0226
443 TRICUSPID VALVE INCOMPETENCE 180 0.0226
444 TACHYPNOEA 308 0.0226
445 HYPERLIPIDAEMIA 270 0.0226
446 HYPOALBUMINAEMIA 175 0.0225
447 DRUG INTOLERANCE 2169 0.0224
448 ANOREXIA 289 0.0224
449 NECK PAIN 1251 0.0224
450 DRY MOUTH 1801 0.0222
451 RASH ERYTHEMATOUS 1059 0.0221
452 HYPERTRANSAMINASAEMIA 154 0.0221
453 FEAR 594 0.0221
454 WHITE BLOOD CELL COUNT INCREASED 845 0.0220
455 CONDITION AGGRAVATED 6681 0.0220
456 ALANINE AMINOTRANSFERASE INCREASED 1349 0.0219
457 WEIGHT INCREASED 4919 0.0219
458 ORTHOSTATIC HYPOTENSION 382 0.0219
459 TACHYCARDIA 1946 0.0219
460 ULCER HAEMORRHAGE 148 0.0218
461 INSOMNIA 5800 0.0218
462 LEUKOPENIA 1087 0.0217
463 NIGHTMARE 751 0.0217
464 ASPARTATE AMINOTRANSFERASE INCREASED 1152 0.0217
465 CYANOSIS 340 0.0216
466 BODY TEMPERATURE INCREASED 441 0.0216
467 RASH PAPULAR 484 0.0216
468 OVERDOSE 4643 0.0215
469 BLOOD ALKALINE PHOSPHATASE INCREASED 532 0.0214
470 MIDDLE INSOMNIA 400 0.0214
471 BRADYCARDIA 1135 0.0214
472 TORSADE DE POINTES 167 0.0213
473 URINARY RETENTION 710 0.0213
474 LOWER RESPIRATORY TRACT INFECTION 965 0.0212
475 SHOCK 487 0.0212
476 BLOOD LACTATE DEHYDROGENASE INCREASED 335 0.0211
477 THERAPEUTIC PRODUCT EFFECT DECREASED 946 0.0211
478 PETECHIAE 220 0.0211
479 DERMATITIS ALLERGIC 265 0.0210
480 NEUROTOXICITY 369 0.0210
481 EMOTIONAL DISORDER 649 0.0210
482 LUNG DISORDER 1030 0.0210
483 FALL 6992 0.0210
484 JOINT DISLOCATION 221 0.0209
485 AUTOIMMUNE DISORDER 203 0.0208
486 MULTIPLE ORGAN DYSFUNCTION SYNDROME 585 0.0206
487 PANIC REACTION 149 0.0206
488 NERVOUSNESS 1077 0.0206
489 FOOT DEFORMITY 228 0.0205
490 PYREXIA 7104 0.0205
491 HEPATIC FUNCTION ABNORMAL 766 0.0205
492 EAR PAIN 398 0.0205
493 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 195 0.0204
494 ANURIA 175 0.0203
495 ATELECTASIS 196 0.0203
496 INTENTIONAL UNDERDOSE 148 0.0202
497 ACUTE RESPIRATORY DISTRESS SYNDROME 357 0.0202
498 IMPAIRED GASTRIC EMPTYING 274 0.0201
499 GAIT DISTURBANCE 3845 0.0201
500 THERAPY NON-RESPONDER 901 0.0200
501 PHOTOSENSITIVITY REACTION 331 0.0200
502 HEMIPARESIS 339 0.0200
503 SCAB 228 0.0200
504 HEPATIC FAILURE 602 0.0199
505 MEDICATION ERROR 1105 0.0199
506 COAGULOPATHY 331 0.0198
507 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 949 0.0197
508 ARTHROPATHY 1098 0.0197
509 ELECTROLYTE IMBALANCE 229 0.0197
510 PANCREATITIS ACUTE 441 0.0196
511 MOBILITY DECREASED 1407 0.0196
512 WHEEZING 1159 0.0195
513 SEXUAL DYSFUNCTION 229 0.0195
514 SLUGGISHNESS 199 0.0195
515 DYSPHAGIA 1851 0.0195
516 RESPIRATORY DISORDER 583 0.0195
517 MULTI-ORGAN FAILURE 336 0.0194
518 ROAD TRAFFIC ACCIDENT 813 0.0194
519 PHARYNGITIS 241 0.0194
520 PREMATURE DELIVERY 309 0.0194
521 RESPIRATORY RATE INCREASED 172 0.0194
522 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1376 0.0193
523 ATRIOVENTRICULAR BLOCK 149 0.0193
524 NO THERAPEUTIC RESPONSE 235 0.0193
525 ACCIDENTAL OVERDOSE 702 0.0192
526 SUBSTANCE ABUSE 156 0.0191
527 IMPAIRED WORK ABILITY 409 0.0191
528 MUSCULOSKELETAL PAIN 1001 0.0191
529 PHARMACEUTICAL PRODUCT COMPLAINT 496 0.0191
530 CHOLESTASIS 365 0.0190
531 LIVER FUNCTION TEST ABNORMAL 552 0.0190
532 CIRCULATORY COLLAPSE 323 0.0189
533 CENTRAL NERVOUS SYSTEM LESION 259 0.0188
534 THERAPY PARTIAL RESPONDER 294 0.0188
535 MUSCLE SPASTICITY 231 0.0188
536 VENTRICULAR TACHYCARDIA 310 0.0188
537 HYPOTHYROIDISM 599 0.0187
538 TUBULOINTERSTITIAL NEPHRITIS 351 0.0187
539 HEPATIC STEATOSIS 348 0.0187
540 ILL-DEFINED DISORDER 1134 0.0186
541 INTENTIONAL PRODUCT USE ISSUE 1627 0.0186
542 EAR INFECTION 494 0.0185
543 BLOOD TRIGLYCERIDES INCREASED 328 0.0185
544 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 318 0.0185
545 RESPIRATORY SYNCYTIAL VIRUS INFECTION 161 0.0185
546 FACIAL PAIN 165 0.0185
547 DIZZINESS 9207 0.0184
548 HEMIPLEGIA 153 0.0184
549 GENERAL PHYSICAL HEALTH DETERIORATION 2123 0.0183
550 ECONOMIC PROBLEM 278 0.0183
551 RASH MACULAR 640 0.0183
552 PARALYSIS 262 0.0183
553 SENSORY LOSS 147 0.0182
554 EYE DISCHARGE 189 0.0182
555 BEDRIDDEN 239 0.0182
556 SKIN LESION 497 0.0181
557 DISABILITY 358 0.0181
558 THERAPY CHANGE 178 0.0181
559 BLADDER DISORDER 179 0.0180
560 HYPOAESTHESIA 2695 0.0180
561 DRUG ABUSE 1496 0.0180
562 ACTIVITIES OF DAILY LIVING IMPAIRED 355 0.0179
563 MUSCULAR WEAKNESS 2035 0.0179
564 ANAL INCONTINENCE 161 0.0179
565 HAEMODIALYSIS 150 0.0178
566 PRODUCT USE IN UNAPPROVED INDICATION 4418 0.0178
567 NERVOUS SYSTEM DISORDER 556 0.0178
568 LOWER LIMB FRACTURE 340 0.0177
569 FOOT FRACTURE 335 0.0177
570 ABNORMAL DREAMS 487 0.0176
571 SWELLING 1648 0.0176
572 ACUTE RESPIRATORY FAILURE 338 0.0176
573 OSTEOPENIA 266 0.0175
574 INJURY 1231 0.0175
575 MENSTRUAL DISORDER 145 0.0175
576 SCAR 299 0.0174
577 CARDIOMEGALY 213 0.0173
578 VISION BLURRED 2371 0.0173
579 DECREASED ACTIVITY 185 0.0171
580 ILEUS 213 0.0171
581 INFUSION RELATED REACTION 1131 0.0170
582 MITRAL VALVE INCOMPETENCE 193 0.0170
583 DENTAL CARIES 188 0.0170
584 PANCREATITIS 898 0.0170
585 TENDERNESS 177 0.0170
586 THROMBOCYTOPENIA 1897 0.0169
587 RESPIRATORY FAILURE 1236 0.0169
588 VOMITING 7928 0.0168
589 EYELID OEDEMA 196 0.0168
590 ORAL PAIN 376 0.0168
591 UNINTENDED PREGNANCY 175 0.0167
592 INABILITY TO AFFORD MEDICATION 166 0.0167
593 DRUG ADMINISTRATION ERROR 513 0.0167
594 MUSCULOSKELETAL STIFFNESS 1462 0.0167
595 RETCHING 355 0.0166
596 RASH PRURITIC 898 0.0166
597 PARAESTHESIA 2601 0.0165
598 MUSCLE TIGHTNESS 267 0.0165
599 ABASIA 407 0.0165
600 HYPOKALAEMIA 759 0.0164
601 CHOKING 320 0.0164
602 HYPOTENSION 3289 0.0164
603 SUPRAVENTRICULAR TACHYCARDIA 156 0.0163
604 ANKLE FRACTURE 252 0.0163
605 THIRST 287 0.0160
606 LACERATION 151 0.0160
607 HAEMATOCRIT DECREASED 317 0.0160
608 THERAPEUTIC RESPONSE UNEXPECTED 717 0.0160
609 LIP SWELLING 531 0.0159
610 SENSORY DISTURBANCE 255 0.0159
611 HYPOPHAGIA 405 0.0158
612 CARDIOGENIC SHOCK 227 0.0158
613 FEELING ABNORMAL 3790 0.0158
614 VENTRICULAR EXTRASYSTOLES 164 0.0158
615 CONTUSION 1517 0.0157
616 REBOUND EFFECT 178 0.0157
617 GASTROENTERITIS VIRAL 284 0.0157
618 SUBDURAL HAEMATOMA 225 0.0157
619 NEPHROLITHIASIS 720 0.0157
620 SCIATICA 250 0.0157
621 VIRAL INFECTION 521 0.0156
622 DYSSTASIA 457 0.0156
623 MALNUTRITION 175 0.0156
624 RIB FRACTURE 321 0.0156
625 SKIN LACERATION 169 0.0155
626 FEEDING DISORDER 315 0.0155
627 SWOLLEN TONGUE 485 0.0155
628 HEPATOTOXICITY 345 0.0155
629 DEMENTIA 432 0.0154
630 PRODUCT ADMINISTRATION ERROR 312 0.0154
631 TOOTH FRACTURE 170 0.0154
632 GASTROINTESTINAL DISORDER 1376 0.0153
633 LIVER DISORDER 681 0.0153
634 DIABETES MELLITUS INADEQUATE CONTROL 271 0.0153
635 DIABETES MELLITUS 1163 0.0152
636 PRODUCT AVAILABILITY ISSUE 347 0.0152
637 BRAIN FOG 238 0.0152
638 QUALITY OF LIFE DECREASED 203 0.0151
639 INSURANCE ISSUE 231 0.0151
640 DRUG INEFFECTIVE 19828 0.0150
641 SPLENOMEGALY 175 0.0149
642 DISEASE RECURRENCE 710 0.0149
643 ADVERSE DRUG REACTION 1338 0.0149
644 PERIPHERAL COLDNESS 204 0.0148
645 SKIN REACTION 209 0.0148
646 OSTEOPOROSIS 609 0.0148
647 HUNGER 206 0.0148
648 WRIST FRACTURE 177 0.0148
649 PALLOR 401 0.0147
650 URTICARIA 2462 0.0147
651 PRODUCT TASTE ABNORMAL 198 0.0146
652 INTENTIONAL DRUG MISUSE 305 0.0146
653 PHARYNGEAL OEDEMA 224 0.0145
654 TEMPERATURE INTOLERANCE 150 0.0145
655 MICTURITION URGENCY 166 0.0145
656 DRUG DOSE OMISSION 2394 0.0145
657 SKIN DISORDER 483 0.0145
658 OXYGEN SATURATION DECREASED 813 0.0145
659 HYPERTENSION 3063 0.0144
660 VISUAL ACUITY REDUCED 480 0.0144
661 VISUAL IMPAIRMENT 1782 0.0144
662 HYPOCALCAEMIA 272 0.0144
663 LYMPHOCYTE COUNT DECREASED 254 0.0144
664 HEPATIC CYTOLYSIS 183 0.0143
665 DECREASED APPETITE 3330 0.0143
666 PRODUCT USE ISSUE 2690 0.0143
667 MUSCLE SPASMS 2619 0.0143
668 OEDEMA 771 0.0142
669 INTERNATIONAL NORMALISED RATIO INCREASED 403 0.0141
670 NEURALGIA 342 0.0141
671 DYSPEPSIA 1379 0.0140
672 ALOPECIA 2745 0.0140
673 PANCYTOPENIA 778 0.0139
674 UNDERDOSE 1016 0.0139
675 HEADACHE 8723 0.0139
676 HEAD DISCOMFORT 246 0.0139
677 BLOOD POTASSIUM DECREASED 417 0.0139
678 INTERVERTEBRAL DISC PROTRUSION 303 0.0138
679 LYMPHOPENIA 196 0.0138
680 JOINT INJURY 296 0.0138
681 HYPOXIA 487 0.0138
682 UPPER RESPIRATORY TRACT INFECTION 638 0.0138
683 DYSURIA 508 0.0138
684 FEELING JITTERY 263 0.0138
685 TINNITUS 633 0.0138
686 ADVERSE EVENT 1268 0.0137
687 SWELLING FACE 894 0.0137
688 ERECTILE DYSFUNCTION 350 0.0136
689 HYPERHIDROSIS 1738 0.0135
690 PRODUCT PRESCRIBING ERROR 321 0.0135
691 ASTHENIA 5065 0.0135
692 PNEUMONIA 4357 0.0134
693 URINARY TRACT INFECTION 2285 0.0134
694 OFF LABEL USE 11652 0.0133
695 PRODUCT QUALITY ISSUE 1807 0.0133
696 ABDOMINAL DISTENSION 1386 0.0133
697 WEIGHT DECREASED 3691 0.0132
698 ARRHYTHMIA 624 0.0132
699 HYPOAESTHESIA ORAL 198 0.0131
700 PRURITUS GENERALISED 284 0.0131
701 UPPER LIMB FRACTURE 261 0.0131
702 RESPIRATORY TRACT INFECTION 341 0.0131
703 SEPTIC SHOCK 568 0.0130
704 ABDOMINAL DISCOMFORT 2188 0.0130
705 PLATELET COUNT INCREASED 170 0.0130
706 HYPERSENSITIVITY 2412 0.0130
707 DRUG PRESCRIBING ERROR 249 0.0129
708 ABDOMINAL PAIN UPPER 2663 0.0129
709 JAUNDICE 347 0.0129
710 ANHEDONIA 338 0.0128
711 HYPERGLYCAEMIA 468 0.0128
712 SYNCOPE 1284 0.0128
713 ACCIDENT 153 0.0128
714 FATIGUE 9946 0.0128
715 EYE DISORDER 419 0.0127
716 RED BLOOD CELL COUNT DECREASED 364 0.0127
717 HEPATIC CIRRHOSIS 237 0.0126
718 THERAPEUTIC RESPONSE DECREASED 764 0.0126
719 ORAL DISCOMFORT 174 0.0125
720 HYPOGLYCAEMIA 606 0.0125
721 PERICARDIAL EFFUSION 288 0.0124
722 CONSTIPATION 2715 0.0124
723 DISCOMFORT 755 0.0124
724 AMENORRHOEA 216 0.0123
725 INTENTIONAL PRODUCT MISUSE 1078 0.0123
726 STAPHYLOCOCCAL INFECTION 404 0.0122
727 BLOOD UREA INCREASED 205 0.0122
728 WRONG TECHNIQUE IN DRUG USAGE PROCESS 444 0.0122
729 PULMONARY CONGESTION 161 0.0122
730 OROPHARYNGEAL PAIN 1117 0.0121
731 COLD SWEAT 212 0.0120
732 NAUSEA 9515 0.0120
733 SEPSIS 1331 0.0119
734 BLINDNESS 483 0.0118
735 CARPAL TUNNEL SYNDROME 166 0.0118
736 POLLAKIURIA 492 0.0118
737 PARAESTHESIA ORAL 170 0.0118
738 DEHYDRATION 1570 0.0118
739 SKIN DISCOLOURATION 540 0.0117
740 RENAL FAILURE ACUTE 497 0.0117
741 PRODUCT DISPENSING ERROR 255 0.0117
742 SKIN EXFOLIATION 987 0.0117
743 DIABETIC KETOACIDOSIS 280 0.0116
744 SEASONAL ALLERGY 164 0.0116
745 HOSPITALISATION 1780 0.0116
746 LOCAL SWELLING 202 0.0116
747 ULCER 184 0.0116
748 BACK DISORDER 188 0.0116
749 LIMB INJURY 314 0.0115
750 GASTRITIS 304 0.0115
751 METRORRHAGIA 197 0.0115
752 GINGIVAL BLEEDING 157 0.0115
753 OEDEMA PERIPHERAL 1399 0.0115
754 MALAISE 5021 0.0114
755 CANDIDA INFECTION 193 0.0114
756 MULTIPLE SCLEROSIS 546 0.0114
757 NASOPHARYNGITIS 2099 0.0114
758 THROAT TIGHTNESS 308 0.0114
759 SURGERY 667 0.0114
760 HEART RATE INCREASED 1117 0.0113
761 ERYTHEMA 2315 0.0113
762 WHITE BLOOD CELL COUNT DECREASED 1218 0.0112
763 PRODUCT USE COMPLAINT 177 0.0112
764 HAEMATOMA 291 0.0112
765 PRURITUS 4315 0.0112
766 ACUTE KIDNEY INJURY 1716 0.0112
767 NEUTROPENIA 1524 0.0112
768 BLOOD BILIRUBIN INCREASED 302 0.0112
769 PERIPHERAL SWELLING 1719 0.0111
770 BRONCHITIS 825 0.0111
771 CHROMATURIA 251 0.0111
772 CHRONIC KIDNEY DISEASE 842 0.0111
773 NEUTROPHIL COUNT DECREASED 451 0.0111
774 IMPAIRED QUALITY OF LIFE 159 0.0110
775 BLOOD PRESSURE DECREASED 734 0.0110
776 BURNING SENSATION 774 0.0110
777 THYROID DISORDER 170 0.0110
778 FEELING HOT 675 0.0110
779 CARDIOMYOPATHY 162 0.0110
780 JOINT SWELLING 1317 0.0109
781 THERAPY CESSATION 560 0.0109
782 INFLUENZA LIKE ILLNESS 889 0.0108
783 DRUG WITHDRAWAL SYNDROME 947 0.0108
784 DERMATITIS 226 0.0108
785 ABDOMINAL PAIN 2496 0.0107
786 HYPOMAGNESAEMIA 149 0.0107
787 PULMONARY FIBROSIS 205 0.0107
788 POST PROCEDURAL COMPLICATION 205 0.0107
789 OCULAR HYPERAEMIA 506 0.0107
790 GASTROENTERITIS 155 0.0106
791 RHEUMATOID ARTHRITIS 1204 0.0106
792 DRUG EFFECT DECREASED 569 0.0106
793 PRODUCT PHYSICAL ISSUE 211 0.0104
794 MENORRHAGIA 205 0.0104
795 EYE PAIN 586 0.0104
796 RENAL FAILURE 1379 0.0104
797 DEAFNESS 271 0.0104
798 END STAGE RENAL DISEASE 189 0.0104
799 PRODUCT DOSE OMISSION ISSUE 3025 0.0103
800 CHEST PAIN 1896 0.0102
801 DRUG WITHDRAWAL SYNDROME NEONATAL 151 0.0102
802 SINUSITIS 1036 0.0101
803 PNEUMOTHORAX 160 0.0101
804 FRACTURE 190 0.0100
805 UNEVALUABLE EVENT 759 0.0100
806 PLEURAL EFFUSION 606 0.0099
807 BLOOD CREATININE INCREASED 648 0.0099
808 MULTIPLE SCLEROSIS RELAPSE 680 0.0099
809 BACTERIAL INFECTION 185 0.0099
810 TOOTHACHE 179 0.0099
811 MUSCULOSKELETAL CHEST PAIN 153 0.0099
812 CYSTITIS 314 0.0099
813 PALPITATIONS 1150 0.0098
814 LIMB DISCOMFORT 302 0.0098
815 INTENTIONAL DOSE OMISSION 278 0.0097
816 CHILLS 1140 0.0097
817 TOOTH DISORDER 216 0.0097
818 BLOOD POTASSIUM INCREASED 157 0.0097
819 HEART RATE DECREASED 339 0.0096
820 PRODUCT PRESCRIBING ISSUE 210 0.0096
821 CELLULITIS 485 0.0096
822 TRANSIENT ISCHAEMIC ATTACK 324 0.0096
823 GALLBLADDER DISORDER 171 0.0096
824 CHOLELITHIASIS 313 0.0095
825 JOINT STIFFNESS 249 0.0095
826 PRODUCT DOSE OMISSION 619 0.0095
827 PAIN 5806 0.0094
828 BLOOD PRESSURE ABNORMAL 187 0.0094
829 FEELING COLD 261 0.0094
830 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 159 0.0094
831 HAEMATEMESIS 237 0.0093
832 HEART RATE IRREGULAR 211 0.0093
833 DRY EYE 466 0.0093
834 KIDNEY INFECTION 183 0.0093
835 INFLUENZA 1033 0.0093
836 KNEE ARTHROPLASTY 195 0.0093
837 CEREBRAL HAEMORRHAGE 331 0.0092
838 INFECTION 1338 0.0092
839 PLATELET COUNT DECREASED 985 0.0092
840 INTESTINAL OBSTRUCTION 348 0.0092
841 BONE MARROW FAILURE 187 0.0092
842 PRESYNCOPE 223 0.0092
843 FREQUENT BOWEL MOVEMENTS 247 0.0091
844 EYE SWELLING 340 0.0091
845 DIARRHOEA 5874 0.0091
846 INJECTION SITE REACTION 624 0.0091
847 ECZEMA 473 0.0090
848 DEEP VEIN THROMBOSIS 586 0.0090
849 SPINAL FRACTURE 180 0.0090
850 DRUG EFFECT INCOMPLETE 326 0.0090
851 HIP FRACTURE 288 0.0089
852 PULMONARY OEDEMA 397 0.0089
853 NEUROPATHY PERIPHERAL 843 0.0089
854 HYPERKALAEMIA 310 0.0088
855 MYALGIA 1498 0.0088
856 PROTEINURIA 167 0.0088
857 PAIN IN EXTREMITY 2577 0.0087
858 DYSPNOEA 4933 0.0087
859 DYSGEUSIA 646 0.0087
860 ILLNESS 892 0.0086
861 HERNIA 167 0.0086
862 GLAUCOMA 166 0.0086
863 CLOSTRIDIUM DIFFICILE INFECTION 188 0.0086
864 BACK PAIN 1995 0.0086
865 SINUS DISORDER 170 0.0086
866 SKIN ULCER 220 0.0085
867 PULMONARY HYPERTENSION 177 0.0085
868 ASTHMA 956 0.0084
869 BLOOD PRESSURE INCREASED 1292 0.0084
870 MUCOSAL INFLAMMATION 219 0.0084
871 HAEMOGLOBIN DECREASED 856 0.0083
872 DYSPHONIA 486 0.0083
873 GASTRIC DISORDER 285 0.0083
874 RENAL IMPAIRMENT 696 0.0083
875 HAEMATURIA 283 0.0083
876 BONE DISORDER 150 0.0082
877 ANAEMIA 1563 0.0082
878 ARTHRALGIA 3405 0.0082
879 ANGIOEDEMA 362 0.0082
880 FLUSHING 828 0.0081
881 PULMONARY EMBOLISM 774 0.0081
882 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 572 0.0080
883 RENAL DISORDER 373 0.0080
884 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 415 0.0079
885 RHINORRHOEA 513 0.0079
886 GASTRIC ULCER 150 0.0079
887 FUNGAL INFECTION 263 0.0079
888 LACTIC ACIDOSIS 255 0.0079
889 INCORRECT PRODUCT ADMINISTRATION DURATION 170 0.0078
890 SKIN FISSURES 153 0.0078
891 COUGH 2187 0.0078
892 EPISTAXIS 583 0.0078
893 TOOTH LOSS 161 0.0078
894 HAEMORRHOIDS 149 0.0076
895 FLATULENCE 433 0.0076
896 ABDOMINAL PAIN LOWER 193 0.0076
897 BLOOD PRESSURE FLUCTUATION 183 0.0076
898 MENSTRUATION IRREGULAR 204 0.0076
899 NASAL CONGESTION 440 0.0075
900 RECTAL HAEMORRHAGE 319 0.0074
901 CHEST DISCOMFORT 757 0.0074
902 BLOOD PRESSURE SYSTOLIC INCREASED 143 0.0073
903 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1485 0.0073
904 SNEEZING 164 0.0073
905 PRODUCT PREPARATION ERROR 148 0.0072
906 PAIN IN JAW 204 0.0072
907 FEMUR FRACTURE 223 0.0072
908 VAGINAL HAEMORRHAGE 312 0.0072
909 CATARACT 425 0.0071
910 THERAPY INTERRUPTED 508 0.0071
911 ARTHRITIS 558 0.0071
912 LABORATORY TEST ABNORMAL 209 0.0071
913 INCORRECT DOSE ADMINISTERED 1614 0.0071
914 ANAPHYLACTIC REACTION 385 0.0070
915 COVID-19 1220 0.0069
916 CEREBROVASCULAR ACCIDENT 1176 0.0069
917 EMOTIONAL DISTRESS 840 0.0069
918 CEREBRAL INFARCTION 169 0.0069
919 RENAL INJURY 205 0.0069
920 FAECES DISCOLOURED 149 0.0069
921 LOCALISED INFECTION 166 0.0069
922 ACNE 520 0.0069
923 LACRIMATION INCREASED 204 0.0067
924 PRODUCTIVE COUGH 321 0.0067
925 ASCITES 196 0.0067
926 FLUID RETENTION 333 0.0065
927 HOT FLUSH 492 0.0065
928 BONE PAIN 382 0.0065
929 HYPOACUSIS 277 0.0064
930 AGEUSIA 160 0.0064
931 EYE IRRITATION 368 0.0064
932 HAEMORRHAGE 661 0.0063
933 THROAT IRRITATION 281 0.0063
934 EYE PRURITUS 209 0.0062
935 ATRIAL FIBRILLATION 605 0.0062
936 BLOOD GLUCOSE DECREASED 298 0.0062
937 THERAPEUTIC RESPONSE SHORTENED 203 0.0061
938 PRODUCT DOSE OMISSION IN ERROR 173 0.0061
939 GYNAECOMASTIA 189 0.0061
940 COLITIS 229 0.0060
941 HAEMOPTYSIS 168 0.0060
942 THROMBOSIS 484 0.0060
943 DYSPNOEA EXERTIONAL 224 0.0059
944 CARDIAC DISORDER 552 0.0059
945 HAEMATOCHEZIA 319 0.0058
946 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1040 0.0058
947 DIVERTICULITIS 158 0.0057
948 HERPES ZOSTER 326 0.0057
949 PROCEDURAL PAIN 156 0.0056
950 PNEUMONITIS 153 0.0056
951 EXPIRED PRODUCT ADMINISTERED 185 0.0056
952 ACUTE MYOCARDIAL INFARCTION 163 0.0055
953 ANGINA PECTORIS 158 0.0055
954 CARDIAC FAILURE 439 0.0055
955 INTERSTITIAL LUNG DISEASE 263 0.0054
956 CORONARY ARTERY DISEASE 159 0.0052
957 DISEASE PROGRESSION 614 0.0052
958 GASTROINTESTINAL HAEMORRHAGE 421 0.0050
959 DEATH 4272 0.0050
960 BLOOD GLUCOSE INCREASED 927 0.0049
961 DRY SKIN 650 0.0049
962 NO ADVERSE EVENT 853 0.0047
963 INJECTION SITE MASS 173 0.0047
964 PSORIASIS 601 0.0046
965 FEBRILE NEUTROPENIA 299 0.0045
966 SKIN BURNING SENSATION 322 0.0045
967 OSTEONECROSIS 147 0.0045
968 DEVICE DISLOCATION 192 0.0044
969 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 148 0.0044
970 EXTRA DOSE ADMINISTERED 177 0.0044
971 CARDIAC FAILURE CONGESTIVE 346 0.0043
972 MYOCARDIAL INFARCTION 735 0.0042
973 DERMATITIS ATOPIC 221 0.0042
974 DRUG DEPENDENCE 670 0.0042
975 COLITIS ULCERATIVE 162 0.0036
976 INJECTION SITE BRUISING 286 0.0036
977 NEOPLASM MALIGNANT 239 0.0036
978 DEVICE BREAKAGE 144 0.0035
979 INJECTION SITE SWELLING 254 0.0033
980 SKIN IRRITATION 149 0.0032
981 INJECTION SITE PAIN 983 0.0032
982 INJECTION SITE HAEMORRHAGE 252 0.0032
983 INJECTION SITE PRURITUS 211 0.0031
984 INJECTION SITE ERYTHEMA 382 0.0031
985 DEVICE ISSUE 275 0.0031
986 DEVICE MALFUNCTION 199 0.0028
987 ACCIDENTAL EXPOSURE TO PRODUCT 275 0.0027
988 MALIGNANT NEOPLASM PROGRESSION 268 0.0026
989 DEVICE EXPULSION 156 0.0024
990 BREAST CANCER 217 0.0023
991 PRODUCT STORAGE ERROR 167 0.0019